nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—hypertension—metabolic syndrome X	0.358	1	CtDrD
Carvedilol—VCAM1—metabolic syndrome X	0.279	1	CbGaD
Carvedilol—NDUFC2—Metformin—metabolic syndrome X	0.252	1	CbGbCtD
Carvedilol—VCAM1—tunica intima—metabolic syndrome X	0.00455	0.105	CbGeAlD
Carvedilol—ADRB3—brown adipose tissue—metabolic syndrome X	0.00302	0.0697	CbGeAlD
Carvedilol—NPPB—artery—metabolic syndrome X	0.0025	0.0577	CbGeAlD
Carvedilol—NPPB—blood vessel—metabolic syndrome X	0.00195	0.045	CbGeAlD
Carvedilol—Angina unstable—Metformin—metabolic syndrome X	0.0019	0.109	CcSEcCtD
Carvedilol—SELE—artery—metabolic syndrome X	0.00169	0.039	CbGeAlD
Carvedilol—VCAM1—artery—metabolic syndrome X	0.00156	0.0359	CbGeAlD
Carvedilol—HIF1A—artery—metabolic syndrome X	0.0015	0.0345	CbGeAlD
Carvedilol—GJA1—artery—metabolic syndrome X	0.00145	0.0335	CbGeAlD
Carvedilol—SELE—endothelium—metabolic syndrome X	0.00143	0.0329	CbGeAlD
Carvedilol—SELE—blood vessel—metabolic syndrome X	0.00132	0.0304	CbGeAlD
Carvedilol—VCAM1—endothelium—metabolic syndrome X	0.00131	0.0303	CbGeAlD
Carvedilol—HIF1A—endothelium—metabolic syndrome X	0.00126	0.0292	CbGeAlD
Carvedilol—GJA1—endothelium—metabolic syndrome X	0.00123	0.0283	CbGeAlD
Carvedilol—VCAM1—blood vessel—metabolic syndrome X	0.00121	0.0279	CbGeAlD
Carvedilol—HIF1A—blood vessel—metabolic syndrome X	0.00117	0.0269	CbGeAlD
Carvedilol—GJA1—blood vessel—metabolic syndrome X	0.00113	0.0261	CbGeAlD
Carvedilol—Sinus congestion—Metformin—metabolic syndrome X	0.000967	0.0554	CcSEcCtD
Carvedilol—NPPB—cardiovascular system—metabolic syndrome X	0.00087	0.0201	CbGeAlD
Carvedilol—Respiratory distress—Metformin—metabolic syndrome X	0.000757	0.0434	CcSEcCtD
Carvedilol—SELE—cardiovascular system—metabolic syndrome X	0.000588	0.0136	CbGeAlD
Carvedilol—Accidental injury—Metformin—metabolic syndrome X	0.000544	0.0312	CcSEcCtD
Carvedilol—VCAM1—cardiovascular system—metabolic syndrome X	0.000541	0.0125	CbGeAlD
Carvedilol—VCAM1—kidney—metabolic syndrome X	0.000529	0.0122	CbGeAlD
Carvedilol—HIF1A—cardiovascular system—metabolic syndrome X	0.00052	0.012	CbGeAlD
Carvedilol—SELE—adipose tissue—metabolic syndrome X	0.000518	0.012	CbGeAlD
Carvedilol—HIF1A—kidney—metabolic syndrome X	0.000509	0.0117	CbGeAlD
Carvedilol—GJA1—cardiovascular system—metabolic syndrome X	0.000505	0.0116	CbGeAlD
Carvedilol—GJA1—kidney—metabolic syndrome X	0.000494	0.0114	CbGeAlD
Carvedilol—VCAM1—adipose tissue—metabolic syndrome X	0.000477	0.011	CbGeAlD
Carvedilol—HIF1A—adipose tissue—metabolic syndrome X	0.000459	0.0106	CbGeAlD
Carvedilol—GJA1—adipose tissue—metabolic syndrome X	0.000445	0.0103	CbGeAlD
Carvedilol—NDUFC2—cardiovascular system—metabolic syndrome X	0.000439	0.0101	CbGeAlD
Carvedilol—Lightheadedness—Metformin—metabolic syndrome X	0.00043	0.0247	CcSEcCtD
Carvedilol—NDUFC2—kidney—metabolic syndrome X	0.00043	0.00991	CbGeAlD
Carvedilol—ADRB3—adipose tissue—metabolic syndrome X	0.000408	0.0094	CbGeAlD
Carvedilol—NDUFC2—adipose tissue—metabolic syndrome X	0.000387	0.00893	CbGeAlD
Carvedilol—Nasal congestion—Metformin—metabolic syndrome X	0.000383	0.022	CcSEcCtD
Carvedilol—Injury—Metformin—metabolic syndrome X	0.00038	0.0218	CcSEcCtD
Carvedilol—Renal impairment—Metformin—metabolic syndrome X	0.000367	0.021	CcSEcCtD
Carvedilol—SELE—liver—metabolic syndrome X	0.000364	0.00838	CbGeAlD
Carvedilol—Hypoglycaemia—Metformin—metabolic syndrome X	0.000358	0.0205	CcSEcCtD
Carvedilol—VEGFA—adipose tissue—metabolic syndrome X	0.000351	0.0081	CbGeAlD
Carvedilol—Pain in extremity—Metformin—metabolic syndrome X	0.000349	0.02	CcSEcCtD
Carvedilol—XDH—kidney—metabolic syndrome X	0.000347	0.008	CbGeAlD
Carvedilol—Migraine—Metformin—metabolic syndrome X	0.000344	0.0197	CcSEcCtD
Carvedilol—VCAM1—liver—metabolic syndrome X	0.000334	0.00771	CbGeAlD
Carvedilol—Dehydration—Metformin—metabolic syndrome X	0.000325	0.0186	CcSEcCtD
Carvedilol—HIF1A—liver—metabolic syndrome X	0.000322	0.00742	CbGeAlD
Carvedilol—Cramp muscle—Metformin—metabolic syndrome X	0.000315	0.018	CcSEcCtD
Carvedilol—Nasopharyngitis—Metformin—metabolic syndrome X	0.000312	0.0179	CcSEcCtD
Carvedilol—GJA1—liver—metabolic syndrome X	0.000312	0.0072	CbGeAlD
Carvedilol—PTGS1—artery—metabolic syndrome X	0.000308	0.00711	CbGeAlD
Carvedilol—Influenza—Metformin—metabolic syndrome X	0.000302	0.0173	CcSEcCtD
Carvedilol—Sweating increased—Metformin—metabolic syndrome X	0.000294	0.0169	CcSEcCtD
Carvedilol—Angina pectoris—Metformin—metabolic syndrome X	0.000294	0.0169	CcSEcCtD
Carvedilol—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000281	0.0161	CcSEcCtD
Carvedilol—NDUFC2—liver—metabolic syndrome X	0.000272	0.00626	CbGeAlD
Carvedilol—PTGS1—endothelium—metabolic syndrome X	0.00026	0.00601	CbGeAlD
Carvedilol—ADRA1B—kidney—metabolic syndrome X	0.00026	0.006	CbGeAlD
Carvedilol—VEGFA—liver—metabolic syndrome X	0.000246	0.00568	CbGeAlD
Carvedilol—Bradycardia—Metformin—metabolic syndrome X	0.000246	0.0141	CcSEcCtD
Carvedilol—Rhinitis—Metformin—metabolic syndrome X	0.000242	0.0139	CcSEcCtD
Carvedilol—Hypoaesthesia—Metformin—metabolic syndrome X	0.00024	0.0138	CcSEcCtD
Carvedilol—PTGS1—blood vessel—metabolic syndrome X	0.00024	0.00554	CbGeAlD
Carvedilol—Oedema peripheral—Metformin—metabolic syndrome X	0.000238	0.0136	CcSEcCtD
Carvedilol—XDH—liver—metabolic syndrome X	0.000219	0.00506	CbGeAlD
Carvedilol—Angiopathy—Metformin—metabolic syndrome X	0.000219	0.0126	CcSEcCtD
Carvedilol—Immune system disorder—Metformin—metabolic syndrome X	0.000218	0.0125	CcSEcCtD
Carvedilol—Mediastinal disorder—Metformin—metabolic syndrome X	0.000218	0.0125	CcSEcCtD
Carvedilol—Malnutrition—Metformin—metabolic syndrome X	0.00021	0.0121	CcSEcCtD
Carvedilol—Flatulence—Metformin—metabolic syndrome X	0.000207	0.0119	CcSEcCtD
Carvedilol—Muscle spasms—Metformin—metabolic syndrome X	0.000202	0.0116	CcSEcCtD
Carvedilol—Vision blurred—Metformin—metabolic syndrome X	0.000198	0.0114	CcSEcCtD
Carvedilol—Ill-defined disorder—Metformin—metabolic syndrome X	0.000195	0.0112	CcSEcCtD
Carvedilol—Malaise—Metformin—metabolic syndrome X	0.00019	0.0109	CcSEcCtD
Carvedilol—ADRB1—cardiovascular system—metabolic syndrome X	0.000189	0.00436	CbGeAlD
Carvedilol—Syncope—Metformin—metabolic syndrome X	0.000189	0.0108	CcSEcCtD
Carvedilol—Palpitations—Metformin—metabolic syndrome X	0.000186	0.0107	CcSEcCtD
Carvedilol—Loss of consciousness—Metformin—metabolic syndrome X	0.000185	0.0106	CcSEcCtD
Carvedilol—Hypertension—Metformin—metabolic syndrome X	0.000182	0.0104	CcSEcCtD
Carvedilol—Chest pain—Metformin—metabolic syndrome X	0.000179	0.0103	CcSEcCtD
Carvedilol—Myalgia—Metformin—metabolic syndrome X	0.000179	0.0103	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000178	0.0102	CcSEcCtD
Carvedilol—Discomfort—Metformin—metabolic syndrome X	0.000177	0.0101	CcSEcCtD
Carvedilol—Oedema—Metformin—metabolic syndrome X	0.000172	0.00984	CcSEcCtD
Carvedilol—Infection—Metformin—metabolic syndrome X	0.000171	0.00978	CcSEcCtD
Carvedilol—Shock—Metformin—metabolic syndrome X	0.000169	0.00968	CcSEcCtD
Carvedilol—Thrombocytopenia—Metformin—metabolic syndrome X	0.000168	0.00963	CcSEcCtD
Carvedilol—ADRB1—adipose tissue—metabolic syndrome X	0.000167	0.00385	CbGeAlD
Carvedilol—Skin disorder—Metformin—metabolic syndrome X	0.000167	0.00956	CcSEcCtD
Carvedilol—Hyperhidrosis—Metformin—metabolic syndrome X	0.000166	0.00951	CcSEcCtD
Carvedilol—Anorexia—Metformin—metabolic syndrome X	0.000164	0.00938	CcSEcCtD
Carvedilol—Hypotension—Metformin—metabolic syndrome X	0.00016	0.0092	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000156	0.00897	CcSEcCtD
Carvedilol—Paraesthesia—Metformin—metabolic syndrome X	0.000154	0.00884	CcSEcCtD
Carvedilol—Dyspnoea—Metformin—metabolic syndrome X	0.000153	0.00877	CcSEcCtD
Carvedilol—Somnolence—Metformin—metabolic syndrome X	0.000153	0.00875	CcSEcCtD
Carvedilol—Dyspepsia—Metformin—metabolic syndrome X	0.000151	0.00866	CcSEcCtD
Carvedilol—ADRA1A—cardiovascular system—metabolic syndrome X	0.00015	0.00345	CbGeAlD
Carvedilol—Decreased appetite—Metformin—metabolic syndrome X	0.000149	0.00855	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000148	0.0085	CcSEcCtD
Carvedilol—Fatigue—Metformin—metabolic syndrome X	0.000148	0.00848	CcSEcCtD
Carvedilol—Constipation—Metformin—metabolic syndrome X	0.000147	0.00842	CcSEcCtD
Carvedilol—KCNH2—cardiovascular system—metabolic syndrome X	0.000144	0.00333	CbGeAlD
Carvedilol—ABCB1—blood vessel—metabolic syndrome X	0.000142	0.00327	CbGeAlD
Carvedilol—Feeling abnormal—Metformin—metabolic syndrome X	0.000141	0.00811	CcSEcCtD
Carvedilol—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00014	0.00805	CcSEcCtD
Carvedilol—ADRA2C—kidney—metabolic syndrome X	0.000139	0.00321	CbGeAlD
Carvedilol—Urticaria—Metformin—metabolic syndrome X	0.000136	0.00782	CcSEcCtD
Carvedilol—Abdominal pain—Metformin—metabolic syndrome X	0.000136	0.00778	CcSEcCtD
Carvedilol—ADRA1A—adipose tissue—metabolic syndrome X	0.000132	0.00304	CbGeAlD
Carvedilol—ADRA2C—adipose tissue—metabolic syndrome X	0.000126	0.0029	CbGeAlD
Carvedilol—Asthenia—Metformin—metabolic syndrome X	0.000123	0.00706	CcSEcCtD
Carvedilol—Pruritus—Metformin—metabolic syndrome X	0.000121	0.00696	CcSEcCtD
Carvedilol—CYP1A1—kidney—metabolic syndrome X	0.000119	0.00275	CbGeAlD
Carvedilol—Diarrhoea—Metformin—metabolic syndrome X	0.000117	0.00673	CcSEcCtD
Carvedilol—CYP2C9—cardiovascular system—metabolic syndrome X	0.000117	0.00271	CbGeAlD
Carvedilol—Dizziness—Metformin—metabolic syndrome X	0.000114	0.00651	CcSEcCtD
Carvedilol—CYP2E1—cardiovascular system—metabolic syndrome X	0.000111	0.00256	CbGeAlD
Carvedilol—Vomiting—Metformin—metabolic syndrome X	0.000109	0.00626	CcSEcCtD
Carvedilol—CYP2E1—kidney—metabolic syndrome X	0.000109	0.00251	CbGeAlD
Carvedilol—Rash—Metformin—metabolic syndrome X	0.000108	0.0062	CcSEcCtD
Carvedilol—Dermatitis—Metformin—metabolic syndrome X	0.000108	0.0062	CcSEcCtD
Carvedilol—CYP1A1—adipose tissue—metabolic syndrome X	0.000108	0.00248	CbGeAlD
Carvedilol—Headache—Metformin—metabolic syndrome X	0.000108	0.00616	CcSEcCtD
Carvedilol—PTGS1—cardiovascular system—metabolic syndrome X	0.000107	0.00247	CbGeAlD
Carvedilol—PTGS1—kidney—metabolic syndrome X	0.000105	0.00242	CbGeAlD
Carvedilol—Nausea—Metformin—metabolic syndrome X	0.000102	0.00585	CcSEcCtD
Carvedilol—ADRA2A—adipose tissue—metabolic syndrome X	0.0001	0.00231	CbGeAlD
Carvedilol—PTGS1—adipose tissue—metabolic syndrome X	9.45e-05	0.00218	CbGeAlD
Carvedilol—ADRA1A—liver—metabolic syndrome X	9.25e-05	0.00213	CbGeAlD
Carvedilol—ADRA2C—liver—metabolic syndrome X	8.81e-05	0.00203	CbGeAlD
Carvedilol—CYP3A4—kidney—metabolic syndrome X	8.76e-05	0.00202	CbGeAlD
Carvedilol—CYP2D6—kidney—metabolic syndrome X	8.62e-05	0.00199	CbGeAlD
Carvedilol—CYP1A2—liver—metabolic syndrome X	7.65e-05	0.00176	CbGeAlD
Carvedilol—CYP1A1—liver—metabolic syndrome X	7.54e-05	0.00174	CbGeAlD
Carvedilol—CYP2C9—liver—metabolic syndrome X	7.26e-05	0.00167	CbGeAlD
Carvedilol—CYP2E1—liver—metabolic syndrome X	6.88e-05	0.00159	CbGeAlD
Carvedilol—ABCB1—cardiovascular system—metabolic syndrome X	6.34e-05	0.00146	CbGeAlD
Carvedilol—ABCB1—kidney—metabolic syndrome X	6.2e-05	0.00143	CbGeAlD
Carvedilol—ABCB1—adipose tissue—metabolic syndrome X	5.59e-05	0.00129	CbGeAlD
Carvedilol—CYP3A4—liver—metabolic syndrome X	5.54e-05	0.00128	CbGeAlD
Carvedilol—CYP2D6—liver—metabolic syndrome X	5.45e-05	0.00126	CbGeAlD
Carvedilol—ABCB1—liver—metabolic syndrome X	3.92e-05	0.000903	CbGeAlD
Carvedilol—ADRA1B—Signaling Pathways—APOA1—metabolic syndrome X	2.05e-06	4.12e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—APOE—metabolic syndrome X	2.05e-06	4.12e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—LPL—metabolic syndrome X	2.05e-06	4.11e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	2.05e-06	4.11e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	2.04e-06	4.09e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IRS1—metabolic syndrome X	2.04e-06	4.09e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	2.03e-06	4.08e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	2.03e-06	4.08e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—APOA1—metabolic syndrome X	2.03e-06	4.07e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IRS1—metabolic syndrome X	2.02e-06	4.05e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	2.02e-06	4.04e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	2.02e-06	4.04e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CD36—metabolic syndrome X	2.01e-06	4.04e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.99e-06	4e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IRS1—metabolic syndrome X	1.99e-06	4e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	1.99e-06	3.99e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PPARA—metabolic syndrome X	1.99e-06	3.98e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—ALB—metabolic syndrome X	1.98e-06	3.97e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—ALB—metabolic syndrome X	1.97e-06	3.96e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GOT1—metabolic syndrome X	1.97e-06	3.95e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GGT1—metabolic syndrome X	1.97e-06	3.95e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—SERPINE1—metabolic syndrome X	1.97e-06	3.94e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GOT1—metabolic syndrome X	1.95e-06	3.92e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GGT1—metabolic syndrome X	1.95e-06	3.92e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—INS—metabolic syndrome X	1.95e-06	3.91e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GOT2—metabolic syndrome X	1.93e-06	3.88e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	1.93e-06	3.88e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—INS—metabolic syndrome X	1.93e-06	3.88e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—AGT—metabolic syndrome X	1.92e-06	3.86e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CCL2—metabolic syndrome X	1.92e-06	3.85e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	1.92e-06	3.85e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—INS—metabolic syndrome X	1.91e-06	3.83e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TGFB1—metabolic syndrome X	1.9e-06	3.82e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CCL2—metabolic syndrome X	1.9e-06	3.81e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TGFB1—metabolic syndrome X	1.9e-06	3.81e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—NOS3—metabolic syndrome X	1.89e-06	3.8e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—NOS3—metabolic syndrome X	1.89e-06	3.79e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IGF1—metabolic syndrome X	1.89e-06	3.78e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	1.88e-06	3.78e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IRS1—metabolic syndrome X	1.88e-06	3.78e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—APOE—metabolic syndrome X	1.88e-06	3.78e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CCL2—metabolic syndrome X	1.88e-06	3.77e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NOS3—metabolic syndrome X	1.88e-06	3.77e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PPARA—metabolic syndrome X	1.87e-06	3.76e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IGF1—metabolic syndrome X	1.87e-06	3.75e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—APOA1—metabolic syndrome X	1.86e-06	3.74e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IRS1—metabolic syndrome X	1.85e-06	3.72e-05	CbGpPWpGaD
Carvedilol—XDH—Metabolism—AKT1—metabolic syndrome X	1.85e-06	3.72e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	1.85e-06	3.71e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	1.85e-06	3.71e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IGF1—metabolic syndrome X	1.84e-06	3.7e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	1.83e-06	3.66e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—AGT—metabolic syndrome X	1.81e-06	3.64e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—INS—metabolic syndrome X	1.8e-06	3.62e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.79e-06	3.59e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PPARG—metabolic syndrome X	1.79e-06	3.59e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—APOE—metabolic syndrome X	1.78e-06	3.56e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—INS—metabolic syndrome X	1.78e-06	3.56e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CCL2—metabolic syndrome X	1.78e-06	3.56e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.77e-06	3.56e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOB—metabolic syndrome X	1.77e-06	3.56e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—APOA1—metabolic syndrome X	1.76e-06	3.52e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—INS—metabolic syndrome X	1.75e-06	3.52e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.75e-06	3.52e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	1.75e-06	3.51e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CCL2—metabolic syndrome X	1.75e-06	3.51e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IGF1—metabolic syndrome X	1.75e-06	3.5e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	1.74e-06	3.5e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.74e-06	3.5e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PTGS2—metabolic syndrome X	1.73e-06	3.47e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PTGS2—metabolic syndrome X	1.73e-06	3.47e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	1.72e-06	3.46e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	1.72e-06	3.46e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	1.72e-06	3.46e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.72e-06	3.45e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IGF1—metabolic syndrome X	1.72e-06	3.45e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	1.72e-06	3.44e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	1.72e-06	3.44e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NOS3—metabolic syndrome X	1.71e-06	3.43e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.71e-06	3.43e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.71e-06	3.43e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.7e-06	3.41e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	1.7e-06	3.4e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NOS3—metabolic syndrome X	1.69e-06	3.4e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—LPL—metabolic syndrome X	1.69e-06	3.4e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NOS3—metabolic syndrome X	1.67e-06	3.36e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOB—metabolic syndrome X	1.67e-06	3.35e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GGT1—metabolic syndrome X	1.67e-06	3.35e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GOT1—metabolic syndrome X	1.67e-06	3.35e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.66e-06	3.33e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOB—metabolic syndrome X	1.66e-06	3.32e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.65e-06	3.31e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	1.65e-06	3.31e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PPARG—metabolic syndrome X	1.64e-06	3.29e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.63e-06	3.27e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	1.62e-06	3.26e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	1.61e-06	3.23e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—INS—metabolic syndrome X	1.61e-06	3.23e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CD36—metabolic syndrome X	1.61e-06	3.23e-05	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—AKT1—metabolic syndrome X	1.61e-06	3.23e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—ALB—metabolic syndrome X	1.61e-06	3.22e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—LPL—metabolic syndrome X	1.59e-06	3.2e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL6—metabolic syndrome X	1.58e-06	3.18e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	1.58e-06	3.18e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—LPL—metabolic syndrome X	1.58e-06	3.17e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	1.58e-06	3.17e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	1.58e-06	3.17e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	1.56e-06	3.13e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	1.55e-06	3.11e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PPARG—metabolic syndrome X	1.55e-06	3.1e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—NOS3—metabolic syndrome X	1.54e-06	3.08e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.53e-06	3.08e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	1.53e-06	3.07e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	1.53e-06	3.06e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—INS—metabolic syndrome X	1.52e-06	3.05e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CD36—metabolic syndrome X	1.52e-06	3.04e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CD36—metabolic syndrome X	1.5e-06	3.01e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PPARA—metabolic syndrome X	1.5e-06	3e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.49e-06	2.99e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.49e-06	2.99e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—ALB—metabolic syndrome X	1.48e-06	2.96e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	1.47e-06	2.94e-05	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—AKT1—metabolic syndrome X	1.46e-06	2.94e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—AKT1—metabolic syndrome X	1.46e-06	2.93e-05	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.45e-06	2.91e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.45e-06	2.91e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—AGT—metabolic syndrome X	1.45e-06	2.91e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL6—metabolic syndrome X	1.44e-06	2.89e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	1.44e-06	2.89e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL6—metabolic syndrome X	1.44e-06	2.88e-05	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—AKT1—metabolic syndrome X	1.43e-06	2.88e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL6—metabolic syndrome X	1.43e-06	2.87e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	1.43e-06	2.87e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOE—metabolic syndrome X	1.42e-06	2.85e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	1.42e-06	2.84e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOB—metabolic syndrome X	1.42e-06	2.84e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—NOS3—metabolic syndrome X	1.41e-06	2.83e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL6—metabolic syndrome X	1.41e-06	2.83e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PPARA—metabolic syndrome X	1.41e-06	2.83e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	1.41e-06	2.82e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOA1—metabolic syndrome X	1.4e-06	2.81e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PPARA—metabolic syndrome X	1.4e-06	2.8e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ALB—metabolic syndrome X	1.39e-06	2.79e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	1.38e-06	2.78e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	1.38e-06	2.76e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—AGT—metabolic syndrome X	1.36e-06	2.74e-05	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	1.36e-06	2.72e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—AGT—metabolic syndrome X	1.35e-06	2.71e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—LPL—metabolic syndrome X	1.35e-06	2.71e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.35e-06	2.7e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOE—metabolic syndrome X	1.34e-06	2.68e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	1.33e-06	2.68e-05	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.33e-06	2.68e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—NOS3—metabolic syndrome X	1.33e-06	2.67e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—AKT1—metabolic syndrome X	1.33e-06	2.67e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	1.33e-06	2.67e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	1.33e-06	2.67e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOE—metabolic syndrome X	1.33e-06	2.66e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—AKT1—metabolic syndrome X	1.32e-06	2.66e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOA1—metabolic syndrome X	1.32e-06	2.65e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—AKT1—metabolic syndrome X	1.32e-06	2.65e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	1.32e-06	2.65e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	1.31e-06	2.64e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOA1—metabolic syndrome X	1.31e-06	2.63e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—AKT1—metabolic syndrome X	1.3e-06	2.61e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PTGS2—metabolic syndrome X	1.29e-06	2.59e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GGT1—metabolic syndrome X	1.29e-06	2.58e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GOT1—metabolic syndrome X	1.29e-06	2.58e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	1.29e-06	2.58e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CD36—metabolic syndrome X	1.28e-06	2.58e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TGFB1—metabolic syndrome X	1.24e-06	2.49e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PPARG—metabolic syndrome X	1.24e-06	2.48e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	1.23e-06	2.47e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PTGS2—metabolic syndrome X	1.22e-06	2.44e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—INS—metabolic syndrome X	1.21e-06	2.43e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	1.21e-06	2.43e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PPARA—metabolic syndrome X	1.19e-06	2.4e-05	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	1.19e-06	2.38e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	1.17e-06	2.34e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PPARG—metabolic syndrome X	1.16e-06	2.34e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AGT—metabolic syndrome X	1.16e-06	2.32e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PPARG—metabolic syndrome X	1.15e-06	2.32e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—INS—metabolic syndrome X	1.14e-06	2.29e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOE—metabolic syndrome X	1.13e-06	2.27e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—INS—metabolic syndrome X	1.13e-06	2.27e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TGFB1—metabolic syndrome X	1.13e-06	2.27e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	1.12e-06	2.25e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOA1—metabolic syndrome X	1.12e-06	2.25e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—ALB—metabolic syndrome X	1.11e-06	2.23e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TGFB1—metabolic syndrome X	1.11e-06	2.22e-05	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	1.1e-06	2.21e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOB—metabolic syndrome X	1.09e-06	2.19e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	1.08e-06	2.18e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	1.08e-06	2.16e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—NOS3—metabolic syndrome X	1.06e-06	2.13e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	1.06e-06	2.13e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ALB—metabolic syndrome X	1.05e-06	2.1e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	1.05e-06	2.1e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—LPL—metabolic syndrome X	1.04e-06	2.09e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ALB—metabolic syndrome X	1.04e-06	2.08e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	1.03e-06	2.07e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—NOS3—metabolic syndrome X	1e-06	2.01e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	1e-06	2.01e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—NOS3—metabolic syndrome X	9.93e-07	1.99e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CD36—metabolic syndrome X	9.91e-07	1.99e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PPARG—metabolic syndrome X	9.87e-07	1.98e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTGS2—metabolic syndrome X	9.72e-07	1.95e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—INS—metabolic syndrome X	9.68e-07	1.94e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL6—metabolic syndrome X	9.35e-07	1.88e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPARA—metabolic syndrome X	9.21e-07	1.85e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	9.16e-07	1.84e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	9.15e-07	1.84e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	9.08e-07	1.82e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AGT—metabolic syndrome X	8.92e-07	1.79e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ALB—metabolic syndrome X	8.87e-07	1.78e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOE—metabolic syndrome X	8.74e-07	1.75e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—AKT1—metabolic syndrome X	8.7e-07	1.75e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—AKT1—metabolic syndrome X	8.68e-07	1.74e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOA1—metabolic syndrome X	8.64e-07	1.73e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—AKT1—metabolic syndrome X	8.63e-07	1.73e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL6—metabolic syndrome X	8.52e-07	1.71e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	8.5e-07	1.71e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—NOS3—metabolic syndrome X	8.49e-07	1.7e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	8.44e-07	1.69e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL6—metabolic syndrome X	8.33e-07	1.67e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	7.88e-07	1.58e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—AKT1—metabolic syndrome X	7.86e-07	1.58e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	7.79e-07	1.56e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	7.76e-07	1.56e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	7.76e-07	1.56e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—AKT1—metabolic syndrome X	7.69e-07	1.54e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPARG—metabolic syndrome X	7.61e-07	1.53e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—INS—metabolic syndrome X	7.47e-07	1.5e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	7.27e-07	1.46e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	7.16e-07	1.44e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—AKT1—metabolic syndrome X	7.07e-07	1.42e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	6.89e-07	1.38e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ALB—metabolic syndrome X	6.85e-07	1.37e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NOS3—metabolic syndrome X	6.55e-07	1.31e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—AKT1—metabolic syndrome X	6.49e-07	1.3e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	6.4e-07	1.29e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	6.36e-07	1.28e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—AKT1—metabolic syndrome X	6.12e-07	1.23e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	5.99e-07	1.2e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	5.91e-07	1.19e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—AKT1—metabolic syndrome X	4.89e-07	9.8e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—AKT1—metabolic syndrome X	4.6e-07	9.24e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—AKT1—metabolic syndrome X	4.56e-07	9.16e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AKT1—metabolic syndrome X	3.9e-07	7.83e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AKT1—metabolic syndrome X	3.01e-07	6.04e-06	CbGpPWpGaD
